Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 16 Source: CRO
- €19 million turnover
-
€3.5 million
profit - 73 employees
-
31st Dec 15 Source: Estimated
- €17 million turnover
- 800 employees
- 1 more year available »
Ranking
By Turnover
(€19 million)- 888th in Top Companies
- 97th in Health
By Employees
(73)- 785th in Top Companies
- 88th in Health
- 73
- €19 million
Employees
- John Eskdale Country Manager
Latest News
- 8:15am Former Quinn firm sues Fermanagh farmer over material posted online
- 7:46am Balark petition to appoint statutory liquidator to Chambury rejected
- 7:00am US investment firms poised to sell Cherrywood land to builders
- 1:00am News publishers highlight importance of journalism in Irish democracy
- Sep 21 From riches to rags: Norwegian trader’s €114m bet backfires